Home
About
Overview
Sharing Data
ORCID
Help
History (26)
Cutting edge: regulation of T cell activation threshold by CD28 costimulation through targeting Cbl-b for ubiquitination.
Weinstein, Robert
Combined-type oral contraceptives and plasma triglyceride and cholesterol levels of young women.
Taenia
Mesothelioma and radical multimodality therapy: who benefits?
See All 26 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Mesothelioma and radical multimodality therapy: who benefits?
Mesothelioma and radical multimodality therapy: who benefits? Chest. 1995 Jun; 107(6 Suppl):345S-350S.
View in:
PubMed
subject areas
Antineoplastic Agents
Chemotherapy, Adjuvant
Clinical Trials as Topic
Humans
Mesothelioma
Pleural Neoplasms
Pneumonectomy
Radiotherapy, Adjuvant
Survival Rate
authors with profiles
Michael Liptay